Xalud Therapeuticsincis A Clinical Stage Biotechnology Company Based In San Franciscocawith An Additional Office In New Yorknyfounded In 2009The Company Focuses On Developing Innovative Treatments For Chronic Inflammatory Diseases Through A Non Viral Gene Therapy Platformtheir Mission Is To Address The Root Causes Of Inflammation By Utilizing Interleukin 10Il 10 A Key Cytokine That Regulates Multiple Inflammatory Pathways The Company Offers A Proprietary Non Viral Plasmid Dnapdnadelivered Gene Therapy Platformwhich Is Designed To Safely Deliver Transgenes For Various Chronic Inflammatoryneurologicaland Autoimmune Diseasestheir Lead Candidatext 150Is A Locally Injectable Gene Therapy That Expresses A Modified Version Of Il 10Aimed At Treating Pathologic Inflammation And Pain In Conditions Such As Musculoskeletal And Neurodegenerative Diseasesxalud Therapeutics Operates Within The Biotechnology And Healthcare Sectorscompeting With Major Pharmaceutical Companies
No conferences found for this company.
| Company Name | Xalud Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
